Safety and tolerability of a 90‐minute rapid infusion of Sandoz biosimilar rituximab in B‐cell lymphoproliferative disorders in a real‐world setting.
Saved in:
| Title: | Safety and tolerability of a 90‐minute rapid infusion of Sandoz biosimilar rituximab in B‐cell lymphoproliferative disorders in a real‐world setting. |
|---|---|
| Authors: | Muntañola, Ana1 (AUTHOR), Arguiñano‐Pérez, José María2 (AUTHOR), Dávila, Julio3 (AUTHOR), de Villambrosia, Sonia González4 (AUTHOR), Carpio, Cecilia5,6 (AUTHOR), Jiménez‐Ubieto, Ana7 (AUTHOR), Salar, Antonio8,9,10 (AUTHOR) asalar@psmar.cat |
| Source: | CTS: Clinical & Translational Science. Feb2023, Vol. 16 Issue 2, p305-312. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 161873782 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety and tolerability of a 90‐minute rapid infusion of Sandoz biosimilar rituximab in B‐cell lymphoproliferative disorders in a real‐world setting. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Muntañola%2C+Ana%22">Muntañola, Ana</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Arguiñano‐Pérez%2C+José+María%22">Arguiñano‐Pérez, José María</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dávila%2C+Julio%22">Dávila, Julio</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22de+Villambrosia%2C+Sonia+González%22">de Villambrosia, Sonia González</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Carpio%2C+Cecilia%22">Carpio, Cecilia</searchLink><relatesTo>5,6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jiménez‐Ubieto%2C+Ana%22">Jiménez‐Ubieto, Ana</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Salar%2C+Antonio%22">Salar, Antonio</searchLink><relatesTo>8,9,10</relatesTo> (AUTHOR)<i> asalar@psmar.cat</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22CTS%3A+Clinical+%26+Translational+Science%22">CTS: Clinical & Translational Science</searchLink>. Feb2023, Vol. 16 Issue 2, p305-312. 8p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=161873782 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/cts.13450 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 8 StartPage: 305 Titles: – TitleFull: Safety and tolerability of a 90‐minute rapid infusion of Sandoz biosimilar rituximab in B‐cell lymphoproliferative disorders in a real‐world setting. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Muntañola, Ana – PersonEntity: Name: NameFull: Arguiñano‐Pérez, José María – PersonEntity: Name: NameFull: Dávila, Julio – PersonEntity: Name: NameFull: de Villambrosia, Sonia González – PersonEntity: Name: NameFull: Carpio, Cecilia – PersonEntity: Name: NameFull: Jiménez‐Ubieto, Ana – PersonEntity: Name: NameFull: Salar, Antonio IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: Feb2023 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 17528054 Numbering: – Type: volume Value: 16 – Type: issue Value: 2 Titles: – TitleFull: CTS: Clinical & Translational Science Type: main |
| ResultId | 1 |